Of note, compared with individuals taking insulin, patients on GLP-1RA medications had a lower risk of liver and pancreas cancer
Feb 2015;95(2):124-131
redrag Sikiri, Sven Seiwerth, eljko Grabarevi, Rudolf Ruman, Marijan Petek, Vjekoslav Jagi, Branko Turkovi, Ivo Rotkvi, Stjepan Mie, Ivan Zorii, Pako Konjevoda, Darko Perovi, Ljubica Jurina, Jadranka eparovi, Miro Hanevaki, Branka Artukovi, Mirna Bratuli, Marina Tiljar, Miro Gjurain, Pavao Mikli, Dinko Stani-Rokotov, Zoran Slobodnjak, Nikola Jelovac, Anton Marovi, The influence of a novel pentadecapeptide, BPC 157, on NG-nitro-l-arginine methylester and l-arginine effects on stomach mucosa integrity and blood pressure, European Journal of Pharmacology, Volume 332, Issue 1, 1997, Pages 23-33, ISSN 0014-2999, Seiwerth S, Rucman R, Turkovic B, Sever M, Klicek R, Radic B, Drmic D, Stupnisek M, Misic M, Vuletic LB, Pavlov KH, Barisic I, Kokot A, Japjec M, Blagaic AB, Tvrdeic A, Rokotov DS, Vrcic H, Staresinic M, Sebecic B, Sikiric P

Food choices : Since GLP1 medications already slow gastric emptying, eating high-fat meals that further delay stomach emptying compounds the effect and worsens symptoms